Literature DB >> 9230820

Aortic valve replacement in the elderly. Risk factors and long-term results.

E E Tseng1, C A Lee, D E Cameron, R S Stuart, P S Greene, M S Sussman, L Watkins, T J Gardner, W A Baumgartner.   

Abstract

OBJECTIVE: The current study was undertaken to determine long-term results of aortic valve replacement (AVR) in the elderly, to ascertain predictors of poor outcome, and to assess quality of life. SUMMARY BACKGROUND DATA: Aortic valve replacement is the procedure of choice for elderly patients with aortic valve disease. The number of patients aged 70 and older requiring AVR continues to increase. However, controversy exists as to whether surgery devoted to this subset reflect a cost-effective approach to attaining a meaningful quality of life.
METHODS: This study reviews data on 247 patients aged 70 to 89 years who underwent isolated AVR between 1980 and 1995; there were 126 men (51%) and 121 women (49%). Follow-up was 97% complete (239/247 patients) for a total of 974.9 patient-years. Mean age was 76.2 +/- 4.8 years. Operative mortality and actuarial survival were determined. Patient age, gender, symptoms, associated diseases, prior conditions, New York Health Association class congestive heart failure, native valve disease, prosthetic valve type, preoperative catheterization data, and early postoperative conditions were analyzed as possible predictors of outcome. Functional recovery was evaluated using the SF-36 quality assessment tool.
RESULTS: Operative mortality was 6.1% (15/247). Multivariate logistic regression showed that poor left ventricular function and preoperative pacemaker insertion were independent predictors of early mortality. After surgery, infection was predictive of early mortality. Overall actuarial survival at 1, 5, and 10 years was 89.5 +/- 2% (198 patients at risk), 69.3 +/- 3.4% (89 patients at risk), and 41.2 +/- 6% (13 patients at risk), respectively. Cox proportional hazards model showed that chronic obstructive pulmonary disease and urgency of operation were independent predictors of poor long-term survival. Postoperative renal failure also was predictive of poor outcome. Using the SF-36 quality assessment tool, elderly patients who underwent AVR scored comparably to their age-matched population norms in seven of eight dimensions of overall health. The exception is mental health.
CONCLUSIONS: Aortic valve replacement in the elderly can be performed with acceptable mortality. Significant preoperative risk factors for early mortality include poor left ventricular function and preoperative pacemaker insertion. Predictors of late mortality include chronic obstructive pulmonary disease and urgency of operation. These results stress the importance of operating on the elderly with aortic valve disease; both long-term survival and functional recovery are excellent.

Entities:  

Mesh:

Year:  1997        PMID: 9230820      PMCID: PMC1190892          DOI: 10.1097/00000658-199706000-00017

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  16 in total

1.  Valve replacement in octogenarians: increased early mortality but good long-term result.

Authors:  M Pasic; T Carrel; A Laske; E Bauer; J Turina; R Jenni; L von Segesser; M Turina
Journal:  Eur Heart J       Date:  1992-04       Impact factor: 29.983

2.  Ten-year experience with aortic valve replacement in 482 patients 70 years of age or older: operative risk and long-term results.

Authors:  A C Galloway; S B Colvin; E A Grossi; F G Baumann; Y P Sabban; R Esposito; G H Ribakove; A T Culliford; J N Slater; E Glassman
Journal:  Ann Thorac Surg       Date:  1990-01       Impact factor: 4.330

3.  Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity.

Authors:  L H Edmunds; R E Clark; L H Cohn; G L Grunkemeier; D C Miller; R D Weisel
Journal:  Ann Thorac Surg       Date:  1996-09       Impact factor: 4.330

4.  The Systolic Hypertension in the Elderly Program: Implications for the Management of Older Hypertensive Patients.

Authors:  W. Dallas Hall
Journal:  Am J Geriatr Cardiol       Date:  1992-07

5.  Aortic valve replacement: procedure of choice in elderly patients with aortic stenosis.

Authors:  D F Pupello; L N Bessone; S P Hiro; E Lopez-Cuenca; M S Glatterer; W W Angell; G Ebra
Journal:  J Card Surg       Date:  1994-03       Impact factor: 1.620

6.  Angiopeptin inhibits intimal hyperplasia after angioplasty in porcine coronary arteries.

Authors:  E D Santoian; J E Schneider; M B Gravanis; M Foegh; N Tarazona; G D Cipolla; S B King
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

7.  Aortic valve replacement: determinants of operative mortality.

Authors:  G W He; T E Acuff; W H Ryan; M B Douthit; R T Bowman; Y H He; M J Mack
Journal:  Ann Thorac Surg       Date:  1994-05       Impact factor: 4.330

8.  Valvular disease in the elderly: influence on surgical results.

Authors:  E A Davis; T J Gardner; A M Gillinov; W A Baumgartner; D E Cameron; V L Gott; R S Stuart; L Watkins; B A Reitz
Journal:  Ann Thorac Surg       Date:  1993-02       Impact factor: 4.330

9.  Long term results of cardiac valve replacement in patients aged 75 years and older.

Authors:  X F Roques; E M Baudet
Journal:  J Cardiovasc Surg (Torino)       Date:  1991 Nov-Dec       Impact factor: 1.888

10.  Aortic valve replacement in the elderly: a comparative assay of potential risk factor modification.

Authors:  S Chocron; J P Etievent; J F Viel; N Meneveau; F Clement; N Schipman; C Taberlet; K Alwan
Journal:  J Heart Valve Dis       Date:  1995-05
View more
  4 in total

1.  Validity of standard gamble utilities in patients referred for aortic valve replacement.

Authors:  Amjad I Hussain; Andrew M Garratt; Jan Otto Beitnes; Lars Gullestad; Kjell I Pettersen
Journal:  Qual Life Res       Date:  2015-11-24       Impact factor: 4.147

2.  [Risk of perioperative mortality and complications following biological aortic valve replacement in elderly patients: stented vs unstented bioprotheses].

Authors:  J Ennker; I Florath; U Rosendahl; S Bauer; E von Hodenberg; I C Ennker
Journal:  Z Kardiol       Date:  2001-12

3.  Quality of life and frailty outcomes following surgical and transcatheter aortic valve replacement.

Authors:  Timothy Luke Surman; John Matthew Abrahams; Jaewon Kim; Hayley Elizabeth Surman; Ross Roberts-Thomson; Joseph Matthew Montarello; James Edwards; Michael Worthington; John Beltrame
Journal:  J Cardiothorac Surg       Date:  2022-05-11       Impact factor: 1.522

Review 4.  Evaluating treatment-specific post-discharge quality-of-life and cost-effectiveness of TAVR and SAVR: Current practice & future directions.

Authors:  Maximilian A Fliegner; Devraj Sukul; Michael P Thompson; Nirav J Shah; Reza Soroushmehr; Jeffrey S McCullough; Donald S Likosky
Journal:  Int J Cardiol Heart Vasc       Date:  2021-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.